#USA #St. Paul #iotaMotion #cochlear implant #iotaSOFT

IotaMotion Advances in Robotic Cochlear Implant Surgery

IotaMotion, Inc., based in St. Paul, Minnesota, has solidified its leadership in the field of robotic cochlear implantation through the announcement of receiving a new US patent, No. 12.558.123. This patent is a crucial enhancement to its intellectual property concerning robot-assisted cochlear implants and signifies a step forward in medical technology. The company is notably recognized for its iotaSOFT® system, a pioneering device that is the first and only FDA-approved robotic-assisted insertion system for cochlear implants, enabling precise electrode placement within the cochlea.

This innovative approach addresses a significant unmet need for the millions of individuals suffering from hearing loss. Studies reveal that only about 5% of the 60 million people globally who are eligible for cochlear implants actually receive them, indicating an urgent need for improved technologies in this area.

Expanding Possibilities with iotaSOFT®

The iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System delivers a controlled and consistent method of electrode insertion, protecting the delicate structures of the inner ear. As the healthcare sector increasingly embraces robotic technologies, it is evident that systems enhancing surgical accuracy can lead to better patient outcomes. The FDA clearance for patients aged four and older exemplifies the technology's applicability and market readiness.

Mike Lobinsky, CEO of iotaMotion, emphasized the significance of this new patent for their company's future: “This new patent expands our strong portfolio of intellectual property, which encompasses systems and methods related to the positioning and control of robots in cochlear implant surgery. As iotaSOFT becomes increasingly integrated into leading cochlear implant centers, the protection of the technologies that standardize and control electrode insertion is essential for maintaining our leadership in this field.”

The iotaSOFT system goes beyond traditional surgical methods, offering precision that minimizes risks and maximizes the effectiveness of the procedure. By allowing for gradual and uniform insertion of electrodes, the device significantly reduces the chances of damage to critical cochlear structures, potentially enhancing auditory health outcomes for patients.

A Global Challenge

According to the World Health Organization, over 430 million individuals worldwide suffer from disabling hearing loss, with a substantial subset being candidates for cochlear implantation. However, the accessibility and adoption of these life-enhancing devices remain alarmingly low. IotaMotion's advances in robotic technologies may help bridge this gap, fostering greater global awareness and integration of cochlear implants in clinical practice.

As robotic-assisted surgical methods become standard practice across various medical procedures, the robust protection of intellectual property will play an instrumental role in driving sustainable innovation and ensuring continuous progress in the healthcare sector.

About IotaMotion

Founded to elevate cochlear implant surgeries through robotics, iotaMotion’s commitment to innovation is clear. Their flagship technology, the iotaSOFT® Insertion System, demonstrates a thoughtful approach towards surgical precision and patient safety. Currently available in the United States, clinical trials are also underway in other global markets as the company seeks to extend its reach and make cochlear implants more accessible.

For more detailed information about IotaMotion and its offerings, interested parties are encouraged to visit www.iotamotion.com and follow the company on platforms like LinkedIn, Twitter, Facebook, and YouTube for the latest updates.

In conclusion, with the acquisition of this new patent, IotaMotion reinforces its commitment to redefining cochlear implantation through technological advancements that promise enhanced patient care and operational efficiency in surgical procedures.